{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:27:35Z","timestamp":1791293255460,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jsat.2014.09.007","type":"journal-article","created":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T17:34:15Z","timestamp":1411752855000},"page":"128-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Buprenorphine\/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0788-1467","authenticated-orcid":false,"given":"William C.","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Ganoczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.B.","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2014.09.007_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/ADM.0b013e31826d1df3","article-title":"Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone","volume":"6","author":"Barry","year":"2012","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2014.09.007_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1521-0391.2012.00327.x","article-title":"Pain and associated substance use among opioid dependent individuals seeking office\u2010based treatment with buprenorphine\u2013naloxone: A needs assessment study","volume":"22","author":"Barry","year":"2013","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2014.09.007_bb0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","article-title":"Prescription opioid abuse in patients presenting for methadone maintenance treatment","volume":"73","author":"Brands","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.09.007_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2125.1981.tb01189.x","article-title":"Sublingual buprenorphine used postoperatively: Clinical observations and preliminary pharmacokinetic analysis","volume":"12","author":"Bullingham","year":"1981","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jsat.2014.09.007_bb0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2009.10.014","article-title":"Predictors of buprenorphine\u2013naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study","volume":"107","author":"Chakrabarti","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.09.007_bb0030","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","article-title":"Pharmacokinetics of the combination tablet of buprenorphine and naloxone","volume":"70","author":"Chiang","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.09.007_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pain.2008.01.001","article-title":"An examination of the synergy of pain and PTSD on quality of life: Additive or multiplicative effects?","volume":"138","author":"Clapp","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jsat.2014.09.007_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jsat.2014.09.007_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MLR.0b013e318277f1ad","article-title":"Agreement between electronic medical record-based and self-administered pain numeric rating scale: Clinical and research implications","volume":"51","author":"Goulet","year":"2013","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2014.09.007_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AJP.0b013e31815ca2b4","article-title":"Buprenorphine: New tricks with an old molecule for pain management","volume":"24","author":"Heit","year":"2008","journal-title":"The Clinical Journal of Pain"},{"key":"10.1016\/j.jsat.2014.09.007_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","article-title":"Buprenorphine: Considerations for pain management","volume":"29","author":"Johnson","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.jsat.2014.09.007_bb0060","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2009.723","article-title":"Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: A randomized controlled trial","volume":"301","author":"Kroenke","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2014.09.007_bb0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.x","article-title":"Current knowledge of buprenorphine and its unique pharmacological profile","volume":"10","author":"Pergolizzi","year":"2010","journal-title":"Pain Practice"},{"key":"10.1016\/j.jsat.2014.09.007_bb0070","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.jsat.2009.12.007","article-title":"Pain and continued opioid use in individuals receiving buprenorphine\u2013naloxone for opioid detoxification: Secondary analyses from the Clinical Trials Network","volume":"38","author":"Potter","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2014.09.007_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/00952990701523706","article-title":"Chronic pain severity in opioid-dependent patients","volume":"34","author":"Potter","year":"2008","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2014.09.007_bb0080","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: Increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214001986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214001986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:41:12Z","timestamp":1760038872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547214001986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0740547214001986"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2014.09.007","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine\/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2014.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}